John R Perfect MD
Professor, Medicine, Duke University School of Medicine
Join to View Full Profile
330 Trent Dr163 Hanes HouseDurham, NC 27710
Phone+1 919-620-4467
Fax+1 919-684-8902
Are you Dr. Perfect?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. John Perfect, MD is an infectious disease specialist in Durham, North Carolina. He is currently licensed to practice medicine in North Carolina and Michigan. He is a Professor at Duke University School of Medicine.
Education & Training
Duke University HospitalFellowship, Infectious Disease, 1977 - 1981
University of MichiganResidency, Internal Medicine, 1975 - 1977
OhioHealth/Riverside Methodist HospitalInternship, Transitional Year, 1974 - 1975
The University of Toledo College of MedicineClass of 1974
Certifications & Licensure
MI State Medical License Current
NC State Medical License 1980 - 2026- NC State Medical License 1977 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Cryptococcal nutrient acquisition and pathogenesis: dining on the host.John R Perfect, James W Kronstad
Microbiology and Molecular Biology Reviews. 2025-03-27 - Antifungal Policy and Practice Across Five Countries: A Qualitative Review.David W Denning, John R Perfect, Neda Milevska-Kostova, Artes Haderi, Hannah Armstrong
Journal of Fungi. 2025-02-19 - Advancing Patient Advocacy in Mycology: Cultivating Collaboration in Education, Research, and Policy.Rob Purdie, Rasha Kuran, Ana Alastruey-Izquierdo, Hatim Sati, Juan Luis Rodriguez-Tudela
Mycopathologia. 2025-01-08
Press Mentions
From Pigeon Guano to the BrainSeptember 20th, 2021- Occult Talaromyces Marneffei Infection Unveiled by the Novel Mp1p Antigen Detection AssayOctober 19th, 2020
iCo Therapeutics Announces Oral Amphotericin B Clinical Advisory BoardOctober 23rd, 2018- Join now to see all
Grant Support
- Population Structure and Clinical Impact of Multi-strain and Mixed-species Cryptococcal InfectionsDUKE UNIVERSITY2023–2025
- Population Structure and Clinical Impact of Multi-strain and Mixed-species Cryptococcal InfectionsDUKE UNIVERSITY2023–2025
